Drugs Made In America Acquisition Corp. Ordinary Shares
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
dmaa · market cap & enterprise value · FMP · as of Jun 8, 2026
Core market cap & key metrics
As of Jun 8, 2026, Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a market cap — also referred to as its net worth or valuation — of $358,076,059, making it one of the top most valuable companies globally. Market Cap = $10.62 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Financial Services sectorAbout Market Cap, Net Worth & Valuation
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a market cap — also referred to as its net worth or valuation — of $358,076,059 as of Jun 8, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Drugs Made In America Acquisition Corp. Ordinary Shares reached its all-time high market cap of $217,855,231.03 on Dec 31, 2025. Comparing the Drugs Made In America Acquisition Corp. Ordinary Shares market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Drugs Made In America Acquisition Corp. Ordinary Shares net worth vs peers and ask how Drugs Made In America Acquisition Corp. Ordinary Shares valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
DMAA market cap · 6 questionsDrugs Made In America Acquisition Corp. Ordinary Shares's net worth — measured as market capitalization — is $358,076,059 as of Jun 8, 2026. It ranks #0 globally. Market Cap = $$10.62 (price) × shares outstanding.